Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: 23rd Congress of the International Association for Breast Cancer Research

A novel phenylacetate-dextran derivative (NaPaC) inhibits breast cancer cell proliferation and modifies their interactions with endothelial cells

S Malherbe, M Bérard, M Di Benedetto, N Peyri, M Crépin, C Legrand and MX Wei

Breast Cancer Res 2001, 3(Suppl 1):A39 doi:10.1186/bcr365

Accesses  

  • Last 30 days: 8 accesses
  • Last 365 days: 81 accesses
  • All time: 752 accesses